-
1.
公开(公告)号:US20170105996A1
公开(公告)日:2017-04-20
申请号:US15294075
申请日:2016-10-14
CPC分类号: A61K31/52 , A61K9/0053 , A61K9/20 , A61K9/2846 , A61K45/06 , A61P1/16 , A61K2300/00
摘要: Methods of treating patients suffering from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), including those also suffering front type II diabetes mellitus (T2DM), with a delayed release pharmaceutical composition comprising 6-mercaptopurine are disclosed.